---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-23-000059"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2023-11-01T23:59:59+00:00"
generated_at: "2026-06-09T03:08:49.390271+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q3 net loss of $14M; rev +6%, adj EBITDA +7%, legal settlement hit

## Summary
- Q3 net loss $14M ($0.05 diluted) vs net income $25M ($0.09) a year ago; includes $35M legal settlement charge.
- Net revenues rose 5.8% to $263M from $249M in Q3 2022.
- Adjusted EBITDA up 7.3% to $134M; Adjusted EPS fell to $0.21 from $0.23 on higher interest expense.
- Company reaffirms full-year 2023 outlook but anticipates results at the lower end of the range.

## SEC filing metadata
- accession: 0001822479-23-000059
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2023-11-01T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000059/0001822479-23-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000059/shc-20231101.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-23-000059
- JSON: https://secwatch.observer/filing/0001822479-23-000059.json
- Plain text: https://secwatch.observer/filing/0001822479-23-000059.txt

## Key facts
- Earnings Releases
  Sotera Health Co reported Q3 2023 results: revenue net revenues of $263 million, net income net loss of $14 million, EPS $0.21 Adjusted EPS. Guidance reaffirmed.
  - Period: Q3 2023
  - Revenue: net revenues of $263 million
  - Net income: net loss of $14 million
  - EPS: $0.21 Adjusted EPS
  - Guidance: reaffirmed
  - Result: reported results
  source text: Sotera Health Reports Third-Quarter and Year-to-Date 2023 Results • Q3 2023 net revenues of $263 million increased 6%, compared to Q3 2022 • Q3 2023 net loss of $14 million or $0.05 per diluted share, compared to net income of $25 million or $0.09 per diluted share in Q3 2022 • Q3 2023 Adjusted EBITDA of $134 million increased 7%, compared to Q3 2022 • Q3 2023 Adjusted EPS of $0.21 decreased $0.02 per diluted share, compared to Q3 2022 driven by higher interest expense • Company reaffirms 2023 outlook, anticipates results at the lower end of the range
  evidence_url: https://www.sec.gov/Archives/edgar/data/1822479/000182247923000059/0001822479-23-000059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.